| Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial HL Atkins, M Bowman, D Allan, G Anstee, DL Arnold, A Bar-Or, ... The Lancet 388 (10044), 576-585, 2016 | 353 | 2016 |
| Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States L Muffly, MC Pasquini, M Martens, R Brazauskas, X Zhu, K Adekola, ... Blood, The Journal of the American Society of Hematology 130 (9), 1156-1164, 2017 | 240 | 2017 |
| Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at … V Gupta, MS Tallman, W He, BR Logan, E Copelan, RP Gale, HJ Khoury, ... Blood, The Journal of the American Society of Hematology 116 (11), 1839-1848, 2010 | 229 | 2010 |
| The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome–negative acute … DI Marks, T Wang, WS Pérez, JH Antin, E Copelan, RP Gale, B George, ... Blood, The Journal of the American Society of Hematology 116 (3), 366-374, 2010 | 212 | 2010 |
| Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors V Gupta, M Eapen, R Brazauskas, J Carreras, M Aljurf, RP Gale, GA Hale, ... Haematologica 95 (12), 2119, 2010 | 201 | 2010 |
| Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI EA Copelan, BK Hamilton, B Avalos, KW Ahn, BJ Bolwell, X Zhu, M Aljurf, ... Blood, The Journal of the American Society of Hematology 122 (24), 3863-3870, 2013 | 186 | 2013 |
| Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche AL Boyd, JC Reid, KR Salci, L Aslostovar, YD Benoit, Z Shapovalova, ... Nature cell biology 19 (11), 1336-1347, 2017 | 184 | 2017 |
| HLA-matched sibling bone marrow transplantation for β-thalassemia major M Sabloff, M Chandy, Z Wang, BR Logan, A Ghavamzadeh, CK Li, ... Blood, The Journal of the American Society of Hematology 117 (5), 1745-1750, 2011 | 154 | 2011 |
| Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer? AM Alousi, J Le-Rademacher, RM Saliba, FR Appelbaum, A Artz, ... Blood, The Journal of the American Society of Hematology 121 (13), 2567-2573, 2013 | 142 | 2013 |
| Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group D Villa, M Crump, T Panzarella, KJ Savage, CL Toze, DA Stewart, ... J Clin Oncol 31 (9), 1164-1171, 2013 | 125 | 2013 |
| Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission DI Marks, WS Pérez, W He, MJ Zhang, MR Bishop, BJ Bolwell, ... Blood, The Journal of the American Society of Hematology 112 (2), 426-434, 2008 | 92 | 2008 |
| Myasthenia gravis treated with autologous hematopoietic stem cell transplantation A Bryant, H Atkins, CE Pringle, D Allan, G Anstee, I Bence-Bruckler, ... JAMA neurology 73 (6), 652-658, 2016 | 91 | 2016 |
| Comparison of outcomes after transplantation of G-CSF–stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients … R Chu, R Brazauskas, F Kan, A Bashey, C Bredeson, B Camitta, ... Biology of Blood and Marrow Transplantation 17 (7), 1018-1024, 2011 | 90 | 2011 |
| Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS‐CAN prospective study R Buckstein, RA Wells, N Zhu, HA Leitch, TJ Nevill, KWL Yee, B Leber, ... British journal of haematology 174 (1), 88-101, 2016 | 87 | 2016 |
| Micro-RNA profiling of exosomes from marrow-derived mesenchymal stromal cells in patients with acute myeloid leukemia: implications in leukemogenesis J Barrera-Ramirez, JR Lavoie, HB Maganti, WL Stanford, C Ito, M Sabloff, ... Stem cell reviews and reports 13, 817-825, 2017 | 83 | 2017 |
| Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors P Chandran, Y Le, Y Li, M Sabloff, J Mehic, M Rosu-Myles, DS Allan Leukemia research 39 (4), 486-493, 2015 | 79 | 2015 |
| Intravenous busulfan compared with total body irradiation pretransplant conditioning for adults with acute lymphoblastic leukemia P Kebriaei, C Anasetti, MJ Zhang, HL Wang, I Aldoss, M de Lima, ... Biology of blood and marrow transplantation 24 (4), 726-733, 2018 | 78 | 2018 |
| Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion … HA Leitch, A Parmar, RA Wells, L Chodirker, N Zhu, TJ Nevill, KWL Yee, ... British Journal of Haematology 179 (1), 83-97, 2017 | 77 | 2017 |
| Scoring system prognostic of outcome in patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome BC Shaffer, KW Ahn, ZH Hu, T Nishihori, AK Malone, D Valcárcel, ... Journal of Clinical Oncology 34 (16), 1864, 2016 | 74 | 2016 |
| Pharmacokinetic exposure equivalence and preliminary efficacy and safety from a randomized cross over phase 3 study (ASCERTAIN study) of an oral hypomethylating agent ASTX727 … G Garcia-Manero, J McCloskey, EA Griffiths, KWL Yee, AM Zeidan, ... Blood 134, 846, 2019 | 71 | 2019 |
